News

April 17, 2019

BRCA1/2 Protection Factor Decreases over Time in Epithelial Ovarian Cancer, Study Reports

News

Women with invasive epithelial ovarian cancer have better survival rates at five years of diagnosis if they carry mutations in the BRCA1 and BRCA2 genes. However, this benefit decreases ... Read more

April 15, 2019

Myriad Seeks FDA Approval of myChoice HRD CDx Diagnostic Test for Ovarian Cancer Patients

News

Myriad Genetics has submitted the first part of a premarket approval application with the U.S. Food and Drug Administration for myChoice HRD CDx, a diagnostic test designed to identify ovarian ... Read more

April 12, 2019April 12, 2019

Long-term Use of Oral Contraceptives Protects Against Deadliest Forms of Ovarian Cancer, Large Study Finds

News

Long-term use of oral contraceptives protects women from the most lethal types of ovarian cancers, a large multi-center study has found. The study, “Oral contraceptive use and risk of ... Read more

April 10, 2019

Viome and Helomics Team Up to Study Possible Links Between Gut Microbiome and Ovarian Cancer

News

With the aim of advancing personalized therapy, a pilot study will investigate a possible correlation between gut microbiome and ovarian cancer. The investigation is the initial development of a ... Read more

April 8, 2019

OncLive Summit Looks at Ovarian Cancer and Soft Tissue Sarcoma

News

A recent OncLive State of the Science Summit focused on new therapies and other issues in ovarian cancer and soft tissue sarcoma. The March 26 event in New York ... Read more

April 5, 2019

Be the Difference Foundation Brings ‘Wheel to Survive’ to Boulder, Colorado

News

To celebrate ovarian cancer survivors while raising funds for research and patient programs, the Be the Difference Foundation will present its signature “Wheel to Survive” event May 19 in ... Read more

April 3, 2019

DPX-Survivac Treatment Continues to Show Promise in Women with Advanced Ovarian Cancer, Early Data Show

News

Treatment with DPX-Survivac plus intermittent low-dose cyclophosphamide continues to show promise in women with advanced recurrent ovarian cancer, the second part of a Phase 1/2 trial shows. Interim data ... Read more

March 29, 2019

Phase 3 Trial Launched to Test TTFields-Taxol Combo on Platinum-resistant Ovarian Cancer

News

Novocure has initiated a Phase 3 trial investigating its Tumor Treating Fields (TTFields) — a method that uses electric fields to disrupt cell division — in combination with Taxol ... Read more

March 27, 2019

Patients with Platinum-sensitive Ovarian Cancer Live Longer on SOTIO’s Immunotherapy, Trial Shows

News

Adding SOTIO’s ovarian cancer immunotherapy DCVAC/OvCa to standard second-line chemotherapy significantly extends the lives of women with advanced ovarian cancer who initially responded to their first-line chemotherapy, a Phase ... Read more

March 25, 2019

Uterine Fluid Analysis May Aid in Early Diagnosis of Aggressive OC

News

Proteomic analysis — the characterization of all proteins present in a cell at a given time — in liquid biopsies from the womb may facilitate the early diagnosis of ... Read more

Pin It on Pinterest